1624117-53-8Relevant articles and documents
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)
Kaniskan, H. ümit,Szewczyk, Magdalena M.,Yu, Zhengtian,Eram, Mohammad S.,Yang, Xiaobao,Schmidt, Keith,Luo, Xiao,Dai, Miao,He, Feng,Zang, Irene,Lin, Ying,Kennedy, Steven,Li, Fengling,Dobrovetsky, Elena,Dong, Aiping,Smil, David,Min, Sun-Joon,Landon, Melissa,Lin-Jones, Jennifer,Huang, Xi-Ping,Roth, Bryan L.,Schapira, Matthieu,Atadja, Peter,Barsyte-Lovejoy, Dalia,Arrowsmith, Cheryl H.,Brown, Peter J.,Zhao, Kehao,Jin, Jian,Vedadi, Masoud
, p. 5166 - 5170 (2015)
PRMT3 catalyzes the asymmetric dimethylation of arginine residues of various proteins. It is essential for maturation of ribosomes, may have a role in lipogenesis, and is implicated in several diseases. A potent, selective, and cell-active PRMT3 inhibitor would be a valuable tool for further investigating PRMT3 biology. Here we report the discovery of the first PRMT3 chemical probe, SGC707, by structure-based optimization of the allosteric PRMT3 inhibitors we reported previously, and thorough characterization of this probe in biochemical, biophysical, and cellular assays. SGC707 is a potent PRMT3 inhibitor (IC50=31±2 nM, KD=53±2 nM) with outstanding selectivity (selective against 31 other methyltransferases and more than 250 non-epigenetic targets). The mechanism of action studies and crystal structure of the PRMT3-SGC707 complex confirm the allosteric inhibition mode. Importantly, SGC707 engages PRMT3 and potently inhibits its methyltransferase activity in cells. It is also bioavailable and suitable for animal studies. This well-characterized chemical probe is an excellent tool to further study the role of PRMT3 in health and disease. High selectivity: The first PRMT3 chemical probe, SGC707, was discovered by structure-based optimization. SGC707 is a potent PRMT3 inhibitor with outstanding selectivity. The mechanism of action studies and crystal structure of the PRMT3-SGC707 complex confirm the allosteric inhibition mode. SGC707 engages PRMT3 and potently inhibits its methyltransferase activity in cells. It is also bioavailable and suitable for animal studies.